Tilray CEO Irwin Simon on potential for growth in CBD/THC beverages

CNBC Television published this video item, entitled “Tilray CEO Irwin Simon on potential for growth in CBD/THC beverages” – below is their description.

Tilray CEO Irwin Simon on his company’s integration of its beer and marijuana businesses.

CNBC Television YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

  • NASA predicts giant asteroid could hit Earth in 2182
  • Family members push to make Surfside condo collapse sight a memorial
  • Analyst Ivy Zelman sees a lot of ‘red flags’ in housing market and is staying on the sidelines
  • In This Story: CBD

    Cannabidiol (CBD) is one of 113 identified cannabinoids in cannabis plants. Clinical research on CBD includes studies related to anxiety, cognition, movement disorders, and pain.

    In the United States, the cannabidiol drug Epidiolex was approved by the Food and Drug Administration in 2018 for the treatment of two epilepsy disorders.

    2 Recent Items: CBD

  • City retailers launch weekend shopping blitz to attract more patrons to the Brisbane CBD | 7NEWS
  • Melbourne protester in hospital with COVID-19 | Coronavirus | 9 News Australia
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.